NRC · NASDAQ
National Research Corporation
$21.94 -0.54 (-2.40%)
Company overview
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that enable the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NASDAQ
- Market cap
- $485M
- Employees
- 368
- Headquarters
- Lincoln, NE
- Website
- nrchealth.com
- CEO
- Trent Green
- Listed
- May 23, 2013
- P/E
- 53.80
- Dividend yield
- 3.27%
Company financials
- Revenue
- $139M
- Gross profit
- $77.4M
- Operating income
- $19.6M
- EBITDA
- $27.8M
- Net income
- $9M
- EPS
- $0.41
- Total assets
- $135M
- Total debt
- $78M
- Gross margin
- 55.85%
- Net margin
- 6.52%
- Earnings yield
- 1.86%
No product segmentation.
Showing FY 2024
NRC
1D
NASDAQ
O21.85H22.60L21.53C22.45+0.52 (+2.37%)Vol93.89K